Myriad Genetics
MYGN
#6699
Rank
C$0.92 B
Marketcap
C$9.90
Share price
-3.27%
Change (1 day)
-56.85%
Change (1 year)

Revenue for Myriad Genetics (MYGN)

Revenue in 2025 (TTM): C$1.16 Billion

According to Myriad Genetics's latest financial reports the company's current revenue (TTM ) is C$1.15 Billion. In 2024 the company made a revenue of C$1.20 Billion an increase over the revenue in the year 2023 that were of C$0.99 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Myriad Genetics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$1.16 B-3.45%
2024 C$1.20 B20.31%
2023 C$0.99 B8.52%
2022 C$0.92 B4.59%
2021 C$0.88 B
2019 C$1.06 B-2.16%
2018 C$1.08 B13.03%
2017 C$0.96 B-4.8%
2016 C$1.00 B-2.58%
2015 C$1.03 B23.13%
2014 C$0.84 B7.21%
2013 C$0.78 B44.7%
2012 C$0.54 B20.32%
2011 C$0.45 B19.57%
2010 C$0.37 B3.7%
2009 C$0.36 B-22.6%
2008 C$0.46 B145.87%
2007 C$0.19 B23.8%
2006 C$0.15 B34.53%
2005 C$0.11 B46.49%
2004 C$78.28 M1.24%
2003 C$77.32 M-17.99%
2002 C$94.29 M20.66%
2001 C$78.14 M25.25%
2000 C$62.39 M48.34%
1999 C$42.06 M16.41%
1998 C$36.13 M19.28%
1997 C$30.29 M148.48%
1996 C$12.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Bio-Rad Laboratories
BIO
C$3.57 B 209.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
C$4.30 B 273.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-C$4.8 Million-100.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$4.31 B 274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$61.20 B 5,212.37%๐Ÿ‡บ๐Ÿ‡ธ USA